IN THE SENATE OF THE UNITED STATES
November 20, 2014
Mr. Sanders introduced the following bill; which was read twice and referred to the Committee on Finance
To extend the requirement that drug manufacturers that increase prices faster than inflation pay an additional rebate to State Medicaid programs to include manufacturers of generic drugs.
This Act may be cited as the
Medicaid Generic Drug Price Fairness Act
Applying the Medicaid additional rebate requirement to manufacturers of generic drugs
Section 1927(c)(3)(A) of the Social Security Act ( 42 U.S.C. 1396r–8(c)(3)(A) ) is amended—
in clause (ii), by striking the period and inserting
by adding at the end the following flush text:
and shall be increased by an amount determined in the same manner as the increase in the amount of a rebate for a single source drug or an innovator multiple source drug is determined under paragraph (2).
The amendments made by this section shall apply to rebate periods beginning on or after the date of enactment of this Act.